Moiani, Arianna
Letort, Gil http://orcid.org/0000-0003-4514-7877
Lizot, Sabrina
Chalumeau, Anne http://orcid.org/0000-0003-3404-1401
Foray, Chloe
Felix, Tristan http://orcid.org/0000-0002-5331-3153
Le Clerre, Diane
Temburni-Blake, Sonal http://orcid.org/0000-0001-6690-7746
Hong, Patrick
Leduc, Sophie http://orcid.org/0009-0001-4207-0870
Pinard, Noemie
Marechal, Alan
Seclen, Eduardo http://orcid.org/0000-0001-5147-9144
Boyne, Alex
Mayer, Louisa http://orcid.org/0000-0003-4905-0669
Hong, Robert
Pulicani, Sylvain http://orcid.org/0000-0001-7631-926X
Galetto, Roman
Gouble, Agnès
Cavazzana, Marina http://orcid.org/0000-0002-0264-0891
Juillerat, Alexandre http://orcid.org/0000-0001-9800-6168
Miccio, Annarita http://orcid.org/0000-0002-3409-9665
Duclert, Aymeric
Duchateau, Philippe http://orcid.org/0000-0002-3491-9168
Valton, Julien http://orcid.org/0000-0003-0826-5401
Article History
Received: 8 August 2023
Accepted: 3 June 2024
First Online: 11 June 2024
Competing interests
: A.Mo., G.L., C.F., DL.C., S.T.B., A.Ma., S.Le., N.P., R.G., L.M., R.H., S.P., A.B., E.S., A.J., A.D., P.D., and J.V. are current employees and equity holder at Cellectis; M.C. and A.Mi. received research funds from Cellectis. S.Li., P.H., and A.G. were employees and equity holders at Cellectis at the time the work was conducted. TALEN® is a Cellectis patented technology. The remaining authors declare no competing interests.